Wtppg on Behalf of Alliance for Biopharmaceutical Competitiveness & Innovation
tax consulting
Based in DC
AI Overview
With $80K in lobbying spend across 5 quarterly filings, Wtppg on Behalf of Alliance for Biopharmaceutical Competitiveness & Innovation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Wtppg on Behalf of Alliance for Biopharmaceutical Competitiveness & Innovation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation
issues related to corporate and international tax reform including, IRC section 965, anti-base erosion provisions, foreign derived intangible income, tax treatment of U.S. sales, and global intangible
issues related to corporate and international tax reform including, IRC sections 904(d), 951A, 250, 59A, 163(j), 954(c)(6), 172, 174 and 965. Issues related to Puerto Rico incentives and excise taxes
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.